Related Experiment Video
Updated: Jun 2, 2026
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Identification of a novel muscle A-type lamin-interacting protein (MLIP)
Elmira Ahmady1, Shelley A Deeke, Seham Rabaa
1University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Abstract:
Mutations in the A-type lamin (LMNA) gene are associated with age-associated degenerative disorders of mesenchymal tissues, such as dilated cardiomyopathy, Emery-Dreifuss muscular dystrophy, and limb-girdle muscular dystrophy. The molecular mechanisms that connect mutations in LMNA with different human diseases are poorly understood. Here, we report the identification of a Muscle-enriched A-type Lamin-interacting Protein, MLIP (C6orf142 and 2310046A06rik), a unique single copy gene that is an innovation of amniotes (reptiles, birds, and mammals). MLIP encodes alternatively spliced variants (23-57 kDa) and possesses several novel structural motifs not found in other proteins. MLIP is expressed ubiquitously and most abundantly in heart, skeletal, and smooth muscle. MLIP interacts directly and co-localizes with lamin A and C in the nuclear envelope. MLIP also co-localizes with promyelocytic leukemia (PML) bodies within the nucleus. PML, like MLIP, is only found in amniotes, suggesting that a functional link between the nuclear envelope and PML bodies may exist through MLIP. Down-regulation of lamin A/C expression by shRNA results in the up-regulation and mislocalization of MLIP. Given that MLIP is expressed most highly in striated and smooth muscle, it is likely to contribute to the mesenchymal phenotypes of laminopathies.
Insights
Researchers identified a novel protein, Muscle-enriched A-type Lamin-interacting Protein (MLIP), that interacts with lamin A/C. MLIP
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Mutations in the A-type lamin (LMNA) gene cause age-associated degenerative disorders affecting mesenchymal tissues.
- The precise molecular mechanisms linking LMNA mutations to human diseases remain unclear.
- Understanding lamin A/C interactions is crucial for deciphering laminopathies.
Purpose of the Study:
- To identify and characterize novel proteins interacting with A-type lamins.
- To investigate the function and localization of a newly discovered protein, MLIP.
- To explore the potential role of MLIP in the pathogenesis of laminopathies.
Main Methods:
- Gene identification and characterization of MLIP (C6orf142).
- Analysis of MLIP expression patterns in various tissues.
- Co-localization studies of MLIP with lamin A/C and PML bodies using immunofluorescence.
- Assessment of MLIP expression and localization following lamin A/C knockdown via shRNA.
Main Results:
- Identification of Muscle-enriched A-type Lamin-interacting Protein (MLIP), a unique amniote gene.
- MLIP interacts directly with and co-localizes with lamin A/C at the nuclear envelope.
- MLIP also co-localizes with promyelocytic leukemia (PML) bodies, suggesting a potential link between nuclear envelope and PML bodies.
- Down-regulation of lamin A/C leads to MLIP up-regulation and mislocalization.
- MLIP is highly expressed in cardiac, skeletal, and smooth muscles.
Conclusions:
- MLIP is a novel A-type lamin-interacting protein found in amniotes.
- MLIP's interaction with lamin A/C and its muscle-specific expression suggest a role in mesenchymal tissue integrity.
- The findings provide new insights into the molecular mechanisms underlying laminopathies and associated degenerative disorders.
